Ngā hua rapu - Meike Brinker
- E whakaatu ana i te 1 - 16 hua o te 16
-
1
-
2
IDF2022-1255 Efficacy and safety of finerenone by age and sex subgroups in patients with chronic kidney disease and type 2 diabetes mā Saakshi Bansal, Stefan D. Anker, George L. Bakris, Gerasimos Filippatos, Peter Rossing, Luís M. Ruilope, R. Birne, M. Canziani, Alfredo E. Farjat, Meike Brinker, Bertram Pitt
I whakaputaina 2023Artigo -
3
Finerenone cardiovascular and kidney outcomes by age and sex: FIDELITY post hoc analysis of two phase 3, multicentre, double-blind trials mā Shweta Bansal, Maria Eugênia Fernandes Canziani, Rita Birne, Stefan D. Anker, George L. Bakris, Gerasimos Filippatos, Peter Rossing, Luís M. Ruilope, Alfredo E. Farjat, Peter Kolkhof, Andrea Lage, Meike Brinker, Bertram Pitt
I whakaputaina 2024Artigo -
4
A prespecified exploratory analysis from FIDELITY examined finerenone use and kidney outcomes in patients with chronic kidney disease and type 2 diabetes mā George L. Bakris, Luís M. Ruilope, Stefan D. Anker, Gerasimos Filippatos, Bertram Pitt, Peter Rossing, Linda P. Fried, Prabir Roy‐Chaudhury, Pantelis Sarafidis, Christiane Ahlers, Meike Brinker, Amer Joseph, Robert Lawatscheck, Rajiv Agarwal
I whakaputaina 2022Artigo -
5
Effects of finerenone in people with chronic kidney disease and type 2 diabetes are independent of <scp>HbA1c</scp> at baseline, <scp>HbA1c</scp> variability, diabetes duration and... mā Janet B. McGill, Rajiv Agarwal, Stefan D. Anker, George L. Bakris, Gerasimos Filippatos, Bertram Pitt, Luís M. Ruilope, Andreas L. Birkenfeld, Maria Luiza Caramori, Meike Brinker, Amer Joseph, Andrea Lage, Robert Lawatscheck, Charlie Scott, Peter Rossing
I whakaputaina 2023Artigo -
6
Outcomes with Finerenone in Participants with Stage 4 CKD and Type 2 Diabetes mā Pantelis Sarafidis, Rajiv Agarwal, Bertram Pitt, Christoph Wanner, Gerasimos Filippatos, John Boletis, Katherine R. Tuttle, Luís M. Ruilope, Peter Rossing, Robert Toto, Stefan D. Anker, Zhihong Liu, Amer Joseph, Christiane Ahlers, Meike Brinker, Robert Lawatscheck, George L. Bakris
I whakaputaina 2023Artigo -
7
Finerenone and effects on mortality in chronic kidney disease and type 2 diabetes: a FIDELITY analysis mā Gerasimos Filippatos, Stefan D. Anker, Phyllis August, Andrew J.S. Coats, James L. Januzzi, Boris Mankovsky, Peter Rossing, Luís M. Ruilope, Bertram Pitt, Pantelis Sarafidis, John R. Teerlink, Chris J. Kapelios, Martin Gebel, Meike Brinker, Amer Joseph, Andrea Lage, George L. Bakris, Rajiv Agarwal
I whakaputaina 2023Artigo -
8
Finerenone, glycaemic status, and heart failure with mildly reduced or preserved ejection fraction: A prespecified analysis of the <scp>FINEARTS</scp>‐<scp>HF</scp> trial mā Jawad H. Butt, Pardeep S. Jhund, Alasdair Henderson, Brian Claggett, Akshay S. Desai, Siniša Car, Meike Brinker, Patrick Schloemer, Prabhakar Viswanathan, Andrea Lage, Katja Rohwedder, Michele Senni, Sanjiv J. Shah, Adriaan A. Voors, Faı̈ez Zannad, Bertram Pitt, Muthiah Vaduganathan, Scott D Solomon, John J.V. McMurray
I whakaputaina 2025Artigo -
9
Finerenone and Kidney Outcomes in Patients with Heart Failure: The FINEARTS-HF Trial mā Finnian R. Mc Causland, Muthiah Vaduganathan, Brian Claggett, Ian J. Kulac, Akshay S. Desai, Pardeep S. Jhund, Alasdair Henderson, Meike Brinker, Robert Perkins, Markus F. Scheerer, Patrick Schloemer, Carolyn S.P. Lam, Michele Senni, Sanjiv J. Shah, Adriaan A. Voors, Faı̈ez Zannad, Bertram Pitt, John J.V. McMurray, Scott D. Solomon
I whakaputaina 2024Artigo -
10
Finerenone in Heart Failure and Chronic Kidney Disease with Type 2 Diabetes: the FINE-HEART pooled analysis of cardiovascular, kidney, and mortality outcomes mā Muthiah Vaduganathan, Gerasimos Filippatos, Brian Claggett, Akshay S. Desai, Pardeep S. Jhund, Alasdair Henderson, Meike Brinker, Peter Kolkhof, Patrick Schloemer, James Lay‐Flurrie, Prabhakar Viswanathan, Carolyn S.P. Lam, Michele Senni, Sanjiv J. Shah, Adriaan A. Voors, Faı̈ez Zannad, Peter Rossing, Luís M. Ruilope, Stefan D. Anker, Bertram Pitt, Rajiv Agarwal, John J.V. McMurray, Scott D. Solomon
I whakaputaina 2024Artigo -
11
Finerenone Reduces New-Onset Atrial Fibrillation across the Spectrum of Cardio-Kidney-Metabolism: the FINE-HEART Pooled Analysis mā Maria Pabón, Gerasimos Filippatos, Brian Claggett, Min Miao, Akshay S. Desai, Pardeep S. Jhund, Alasdair Henderson, Meike Brinker, Patrick Schloemer, Lucas H. Hofmeister, Li Li, Siniša Car, Michele Senni, Sanjiv J. Shah, Adriaan A. Voors, Faı̈ez Zannad, Peter Rossing, Luís M. Ruilope, Stefan D. Anker, Bertram Pitt, Rajiv Agarwal, John J.V. McMurray, Scott D. Solomon, Muthiah Vaduganathan
I whakaputaina 2025Artigo -
12
The efficacy of finerenone on hierarchical composite endpoint analysed using win statistics in patients with heart failure and mildly reduced or preserved ejection fraction: A pres... mā Toru Kondo, Pardeep S. Jhund, Alasdair Henderson, Brian Claggett, Akshay S. Desai, Meike Brinker, James Lay‐Flurrie, Patrick Schloemer, Prabhakar Viswanathan, Flaviana Amarante, Chern‐En Chiang, Jingmei Li, Carolyn S.P. Lam, Mark C. Petrie, Michele Senni, Morten Schou, Subodh Verma, Adriaan A. Voors, Dirk von Lewinski, Faiez Zannad, Bertram Pitt, Muthiah Vaduganathan, Scott D. Solomon, John J.V. McMurray
I whakaputaina 2025Artigo -
13
Initial Decline in Glomerular Filtration Rate With Finerenone in HFmrEF/HFpEF mā Shingo Matsumoto, Pardeep S. Jhund, Alasdair Henderson, Johann Bauersachs, Brian Claggett, Akshay S. Desai, Meike Brinker, Patrick Schloemer, Prabhakar Viswanathan, Jon W. Mares, Andrea Scalise, Carolyn S.P. Lam, Gerard C.M. Linssen, José Francisco Kerr Saraiva, Michele Senni, Richard W. Troughton, Jacob A. Udell, Adriaan A Voors, Faı̈ez Zannad, Bertram Pitt, Muthiah Vaduganathan, Scott D. Solomon, John J.V. McMurray
I whakaputaina 2025Artigo -
14
Efficacy and Safety of Finerenone in Heart Failure With Preserved Ejection Fraction mā John W. Ostrominski, Jingmei Li, Brian Claggett, Zi Michael Miao, Akshay S. Desai, Pardeep S. Jhund, Alasdair Henderson, Markus F. Scheerer, Katja Rohwedder, Flaviana Amarante, Meike Brinker, James Lay‐Flurrie, Carolyn S.P. Lam, Michele Senni, Sanjiv J. Shah, Adriaan A. Voors, Faiez Zannad, Peter Rossing, Luís M. Ruilope, Stefan D. Anker, Bertram Pitt, Rajiv Agarwal, John J.V. McMurray, Scott D Solomon, Muthiah Vaduganathan
I whakaputaina 2025Artigo -
15
Design and baseline characteristics of the Finerenone, in addition to standard of care, on the progression of kidney disease in patients with Non-Diabetic Chronic Kidney Disease (F... mā Hiddo J.L. Heerspink, Rajiv Agarwal, George L. Bakris, David Z.I. Cherney, Carolyn S.P. Lam, Brendon L. Neuen, Pantelis Sarafidis, Katherine R. Tuttle, Christoph Wanner, Meike Brinker, Sara Dizayee, Peter Kolkhof, Patrick Schloemer, Paula Vesterinen, Vlado Perkovic, Julio Bittar, Cesar Javier Zaidman, Natalia Cluigt, Miguel Hominal, Paola Aguerre, Fernando Halac, Elizabeth Gelersztein, M. Arriola, Rafaël Maldonado, Mariano Chahin, David Packham, Darren J. Lee, Eugenia Pedagogos, Celine Foote, Sunil V. Badve, Carmel M. Hawley, Jenny Chen, Nicholas A. Gray, Marijn M. Speeckaert, Laura Labriola, Peter Doubel, Bart Maes, Kathleen Claes, Bernard Dubois, Irena Dimitrova, Tsvetelina Vutova, Stefan Ilchev, Svetla Stamova, Yordanka Ivanova, А М Васильева, Xiangmei Chen, Shuifu Tang, Xudong Xu, Bi‐Cheng Liu, Weiming He, Yani He, Fang Liu, Caili Wang, Lianhua Chen, Jianying Niu, Deguang Wang, Ping Luo, Yunhong Xia, Gengru Jiang, Qun Luo, Fang Wang, Menghua Chen, Hongli Lin, Rui Yan, Yinan Li, Qinkai Chen, Junwu Dong, Fei Xiong, Haibo Long, Hong Cheng, Yuehong Li, Juan Du, Fanna Liu, Qingping Chen, Wanhong Lu, Chaosheng Chen, Jianqin Wang, Lei Liu, Min Yang, Gang Long, Yongjun Shi, Wenge Li, Xiangdong Yang, Aicheng Yang, Jianfei Li, Xiaoyan Meng, Martin Prázný, Lucie Hornova, Petr Bucek, Mária Majerníková, Jan Wirth, Jitka Řehořová, Mads Hornum, Jesper Nørgaard Bech, Morten Lindhardt, Ditte Hansen, Line Mortensen, Claus Bogh Juhl, Ioannis Boletis, Dorothea Papadopoulou
I whakaputaina 2024Artigo -
16
Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes According to Baseline HbA1c and Insulin Use: An Analysis From the FIDELIO-DKD Study mā Peter Rossing, Ellen Burgess, Rajiv Agarwal, Stefan D. Anker, Gerasimos Filippatos, Bertram Pitt, Luís M. Ruilope, Pieter Gillard, Richard J. MacIsaac, Julio Wainstein, Amer Joseph, Meike Brinker, Lothar Roessig, Charlie Scott, George L. Bakris, Augusto Vallejos, Richard J. MacIsaac, Guntram Schernthaner, Pieter Gillard, Maria Eugênia Fernandes Canziani, Theodora Temelkova‐Kurktschiev, Ellen Burgess, Sheldon W. Tobe, Fernando González, Zhihong Liu, Andrés Ángelo, Cadena Bonfanti, Carlos Jaramillo, Martin Prázný, Peter Rossing, Jorma Strand, Michel Marre, Roland E. Schmieder, Christoph Wanner, Pantelis Sarafidis, Juliana C.N. Chan, László Rosivall, Joseph A. Eustace, Ehud Grossman, Yoram Yagil, Giuseppe Remuzzi, Daisuke Koya, Takashi Wada, Magdalena Madero Rovalo, Ron T. Gansevoort, Adriaan Kooy, Trine Finnes, Froilan De Leon, Janusz Gumprecht, Fernando Teixeira e Costa, Alexander Dreval, Anantharaman Vathsala, Aslam Amod, Sin Gon Kim, Byung‐Wan Lee, Julio Pascual Santos, Bengt-Olov Tengmark, Michel Burnier, Chien‐Te Lee, Sukit Yamwong, Ramazan Sarı, Kieran McCafferty, Borys Mankovsky, Sharon G. Adler, Linda P. Fried, Robert Toto, Mark V. Williams, Tran Quang Khanh, Diego Aizenberg, Inés Bartolacci, Diego Besada, Julio Bittar, Mariano Chahin, Alicia Elbert, Elizabeth Gelersztein, Alberto Liberman, Laura Maffei, Federico Pérez Manghi, Hugo Sanabria, Gloria Viñes, Alfredo Wassermann, Walter P. Abhayaratna, Shamasunder Acharya, Elif I. Ekinci, Darren Lee, Peak Mann Mah, Craig Nelson, David Packham, Alexia Pape, Simon D. Roger, Hugo Stephenson, Michael Suranyi, Gary Wittert, Elizabeth Vale, Martin Clodi, Christoph Ebenbichler, Evelyn Fließer-Görzer, Ursula Hanusch, Michael Krebs, Karl Lhotta
I whakaputaina 2022Artigo
Ngā utauta rapu:
Ngā marau whai pānga
Internal medicine
Medicine
Diabetes mellitus
Endocrinology
Type 2 diabetes
Heart failure
Kidney disease
Cardiology
Intensive care medicine
Alternative medicine
Pathology
Placebo
Randomized controlled trial
Renal function
Confidence interval
Disease
Ejection fraction
Law
MEDLINE
Political science
Baseline (sea)
Clinical endpoint
Geology
Oceanography
Adverse effect
Albuminuria
Art
Atrial fibrillation
Biology
Clinical trial